CanSinoBIO Says COVID-19 Shot May Be Less Effective Over Time, Booster Shot Promising
BEIJING (Reuters) – China’s CanSino Biologics Inc said the efficacy rate for its single-dose COVID-19 vaccine may fall over time
Read moreBEIJING (Reuters) – China’s CanSino Biologics Inc said the efficacy rate for its single-dose COVID-19 vaccine may fall over time
Read moreRachel Presti, MD, PhD, an infectious diseases physician who led Washington University School of Medicine’s participation in the Johnson &
Read moreAt least 11 states will open vaccine eligibility to all adults this week in a major expansion of COVID-19 shots
Read moreROME (Reuters) – When alarm about potential side effects of AstraZeneca’s COVID-19 shot halted vaccinations around Europe this month, many
Read moreGENEVA/ZURICH (Reuters) – More producers of COVID-19 vaccines should follow AstraZeneca’s lead and license technology to other manufacturers, the World
Read moreHAVANA (Reuters) – Cuba’s drug regulatory authority on Thursday approved a second COVID-19 vaccine candidate for late-stage clinical trials as
Read moreThe arrival of effective vaccines against COVID-19 has been one of the few good news stories of the pandemic. However,
Read moreModerna has begun testing its COVID-19 vaccine in children between the ages of 6 months and 12 years. The biotech
Read moreBRUSSELS (Reuters) – The European Union’s executive will propose next week that new COVID-19 certificates combine information on vaccination, recovery
Read moreVaccinating adults age 26 and older against the human papillomavirus (HPV)—the virus that causes more than 90% of cervical cancers
Read more